BMS 100 852 (Sprycel 100 mg)
Generic Name: dasatinib
Pill with imprint BMS 100 852 is White, Elliptical / Oval and has been identified as Sprycel 100 mg. It is supplied by Bristol-Myers Squibb.
Sprycel is used in the treatment of chronic myelogenous leukemia; acute lymphoblastic leukemia; leukemia and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Sprycel 100 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for BMS 100 852
Sprycel
- Generic Name:
- dasatinib
- Imprint:
- BMS 100 852
- Strength:
- 100 mg
- Color:
- White
- Size:
- 15.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- BCR-ABL tyrosine kinase inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Bristol-Myers Squibb
- National Drug Code (NDC):
- 00003-0852
- Inactive Ingredients:
-
- lactose monohydrate
- microcrystalline cellulose
- croscarmellose sodium
- magnesium stearate
- titanium dioxide
Note: Inactive ingredients may vary.
More about Sprycel (dasatinib)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Pricing & Coupons
- En Español
- 16 Reviews
- Drug class: BCR-ABL tyrosine kinase inhibitors
- FDA Alerts (1)
- FDA Approval History
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
